Anticoagulants and antiplatelet drugs during cataract surgery
Carregando...
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2018
Editora
CONSEL BRASIL OFTALMOLOGIA
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, v.81, n.4, p.348-353, 2018
Resumo
Patients undergoing cataract surgery are generally elderly, and many take drugs with systemic effects. The surgeon must be aware of the risks of continuing or discontinuing such medications perioperatively. Antiplatelet drugs and anticoagulants, prescribed to reduce the incidence of thromboembolic events, are often used in this population. This paper aims to review the perioperative use of antiplatelet and anticoagulant drugs in the setting of cataract surgery. Topical or intracameral anesthesia is preferred over anesthesia injected with needles. Aspirin can be safely continued in patients undergoing cataract surgery. Warfarin has been extensively studied, and the risk of hemorrhage associated with cataract surgery is low if the international normalized ratio is in the therapeutic range. Only a few studies of direct oral anticoagulants are available, and therefore no definite recommendations regarding those agents can be made at this time. Anesthesia in cataract surgery carries a low risk, even for patients taking anticoagulant or antiplatelet drugs. The discontinuation of this class of drugs before cataract surgery may increase the risk of thromboembolism.
Palavras-chave
Anticoagulants, Platelet aggregation inhibitors, Cataract extraction, Risk factors
Referências
- Caligaris LSA, 2011, REV PANAM SALUD PUBL, V29, P428, DOI 10.1590/S1020-49892011000600008
- Alhassan MB, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004083.pub3
- Assia EI, 1998, J CATARACT REFR SURG, V24, P1243, DOI 10.1016/S0886-3350(98)80020-5
- Bartholomay E, 2014, CLINICS, V69, P615, DOI 10.6061/clinics/2014(09)07
- Benzimra JD, 2009, EYE, V23, P10, DOI 10.1038/sj.eye.6703069
- Blum RA, 2016, J CATARACT REFR SURG, V42, P171, DOI 10.1016/j.jcrs.2015.12.002
- Born G, 2006, BRIT J PHARMACOL, V147, pS241, DOI 10.1038/sj.bjp.0706401
- Carter K, 1998, J CATARACT REFR SURG, V24, P1361, DOI 10.1016/S0886-3350(98)80229-0
- Christos S, 2016, WEST J EMERG MED, V17, P264, DOI 10.5811/westjem.2016.3.29294
- Davies BR, 2004, BRIT J OPHTHALMOL, V88, P1226, DOI 10.1136/bjo.2004.045997
- DAVIS DB, 1994, J CATARACT REFR SURG, V20, P327, DOI 10.1016/S0886-3350(13)80586-X
- Di Legge S, 2012, STROKE RES TREAT, DOI 10.1155/2012/391538
- Ernst A, 2006, CHEST, V129, P734, DOI 10.1378/chest.129.3.734
- Ezra DG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005276.pub2
- Faraoni D, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0930-9
- Garcia DA, 2012, CHEST, V141, pE24S, DOI 10.1378/chest.11-2291
- Grzybowski A, 2015, CURR OPIN OPHTHALMOL, V26, P28, DOI 10.1097/ICU.0000000000000117
- Grzybowski A, 2014, BRIT J OPHTHALMOL, V98, P1137, DOI 10.1136/bjophthalmol-2014-305411
- Gualandro DM, 2017, ARQ BRAS CARDIOL, V109
- Hosoda Y, 2016, CLIN OPHTHALMOL, V10, DOI 10.2147/OPTH.S109360
- Jafri SM, 2004, AM HEART J, V147, P3, DOI 10.1016/j.ahj.2003.06.001
- JUN M, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/BMJ.J4323
- Kara N, 2015, ARQ BRAS OFTALMOL, V78, P173, DOI 10.5935/0004-2749.20150044
- Katz J, 2003, OPHTHALMOLOGY, V110, P1784, DOI 10.1016/S0161-6420(03)00785-1
- Keay L, 2012, COCHRANE DB SYST REV, V3
- Kiire CA, 2014, BRIT J OPHTHALMOL, V98, P1320, DOI 10.1136/bjophthalmol-2014-304902
- Kobayashi H, 2010, J CATARACT REFR SURG, V36, P1115, DOI 10.1016/j.jcrs.2010.01.017
- Kong KL, 2015, BRIT J OPHTHALMOL, V99, P1025, DOI 10.1136/bjophthalmol-2014-306036
- Konstantatos A, 2001, ANAESTH INTENS CARE, V29, P11
- Kumar N, 2006, J CATARACT REFR SURG, V32, P1022, DOI 10.1016/j.jcrs.2006.02.035
- Leong JY, 2005, ANN THORAC SURG, V80, P928, DOI 10.1016/j.athoracsur.2005.03.074
- Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298
- Lip GYH, 2010, EUR HEART J, V31, P1311, DOI 10.1093/eurheartj/ehq117
- Lira RPC, 2003, REV SAUDE PUBL, V37, P197, DOI 10.1590/S0034-89102003000200006
- Lorga AM, 2013, ARQ BRAS CARDIOL, V101, P1, DOI 10.5935/abc.2013S009
- Mancl Erin E, 2013, J Pharm Pract, V26, P43, DOI 10.1177/0897190012465989
- Michalska-Malecka K, 2013, CLIN INTERV AGING, V8, P1041, DOI 10.2147/CIA.S44834
- Olson RJ, 2017, OPHTHALMOLOGY, V124, pP1, DOI 10.1016/j.ophtha.2016.09.027
- Patrono C, 2017, J AM COLL CARDIOL, V70, P1760, DOI 10.1016/j.jacc.2017.08.037
- Payal AR, 2016, J CATARACT REFR SURG, V42, P972, DOI 10.1016/j.jcrs.2016.04.032
- Pinho C, 2007, CLINICS, V62, P17, DOI 10.1590/S1807-59322007000100004
- The Royal College of Ophthalmologists, 2004, CAT SURG GUID
- World Health Organization, 2002, REP WHO WORK GROUP
- Zhang Y, 2017, J OPHTHALMOL, V2017